Bing X. Xu
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 176 publications
Concordance of PD-1 expression on paired peripheral and bone marrow T cells: Surrogate potential and clinical implications in DLBCL.
Journal: The International journal of biological markers
Published: August 31, 2026
Early Follicular Lymphoma Grading via PET-CT Fusion and Bayesian Deep Learning.
Journal: Journal of imaging informatics in medicine
Published: May 27, 2026
Rewiring NADH Metabolism Through NQO1-Mediated Redox Cycling for Targeted Follicular Lymphoma Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 21, 2026
A deep learning PET/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 14, 2026
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: December 23, 2025
Novel Isoidide Subunit-Containing Xanthine Oxidase Inhibitors with Potent Hypouricemic Effects.
Journal: Journal of medicinal chemistry
Published: November 28, 2025
A Photoelectrocatalytic Platform for Sequence-Unrestricted Modification of Oligonucleotide Backbones.
Journal: Angewandte Chemie (International ed. in English)
Published: November 10, 2025
Dual targeting of PI3Kδ and PPARα enhances antitumor activity via FoxO1 activation in follicular lymphoma.
Journal: Cell death & disease
Published: September 15, 2025
Dual epigenetic and nuclear export inhibition by chidamide and selinexor in high grade B-cell lymphomas via survivin and PI3K/AKT inhibition.
Journal: Clinical epigenetics
Published: July 18, 2025
Discovery of Pyrazole-Containing 4‑Arylindolines as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.
Journal: ACS medicinal chemistry letters
Published: July 09, 2025
Combination of HDAC inhibitor and PI3K inhibitor suppresses autophagy and induces apoptosis via cytoplasmic IκBα stabilization in p53-mutant diffuse large B-cell lymphoma.
Journal: Cell death discovery
Published: May 21, 2025
Last Updated: 09/26/2026